Pharmaceutical industry lobbying in Brussels is blocking any solution to the growing problem of extremely high medicine prices in Europe, a new report by Corporate Europe Observatory claims. It says the crisis of affordability that has “long plagued” health care systems in the Global South has reached the European Union, as the “industry’s profit maximisation logic…